
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Johanna Simon is the principal scientist formulation service for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.

Published: October 7th 2022 | Updated: